Skip to main content
Fig. 4 | BMC Nephrology

Fig. 4

From: Role of sodium/glucose cotransporter inhibition on a rat model of angiotensin II–dependent kidney damage

Fig. 4

Glucose Uptake (a) and representative immunohistochemical staining for Reactive Oxygen Species (b) in rats infused for 2 weeks with vehicle (Control), Angiotensin II (Ang), Ang II plus Losartan treatment (Ang-Los), Ang II plus Empagliflozin treatment (Ang-Emp) and Ang II plus the combination of Losartan and Empagliflozin treatment (Ang-Los-Emp). In B, the graph represents semiquantitative analysis of fluorescence intensity of the immunohistochemical staining. Each bar represents the mean ± SE of 5 different rats for each experimental group, *p < 0.05 compared vs vehicle, + p < 0.05 compared vs Ang II

Back to article page